Vice Minister of Justice heads Cuban delegation to the Sixty-Eighth Session of the Commission on Narcotic Drugs
Vienna, March 9.-The Deputy Minister of Justice of the Republic of Cuba, Pilar Varona Estrada, arrived in Vienna to lead the Cuban delegation to the Sixty-eighth Session of the Commission on Narcotic Drugs (CND), to be held from March 10 to 14, 2025.
Cuba reaffirms its commitment to contribute internationally to efforts to confront the world drug problem from its “zero tolerance” stance
Cuba focuses its efforts on preventive and educational policies, with the joint participation of all actors in society, under the principles of accessibility, non-discrimination and comprehensiveness, complemented by the implementation of the national plan to combat crime, in compliance with the law and respect for our international commitments.
Cuba thanks the IAEA and its Department of Technical Cooperation for the assistance offered to our country
Speech by Ambassador Pablo Berti Oliva on behalf of the Cuban delegation to the Board of Governors of the International Atomic Energy Agency. March 3-7, 2025.
Item 6: “Strengthening the Agency's activities related to science, technology and nuclear applications”.
Mr. Chairman:
The Cuban delegation thanks the Director General for his report GOV/2025/4, of which we take note.
Cuba denounces undue restrictions on exports of peaceful nuclear materials, equipment and technologies to developing countries
Speech by the Second Secretary, Karlén Isrober Regaiferos Cruzata, representing the Cuban delegation to the Board of Governors of the International Atomic Energy Agency. March 3-7, 2025.
Item 5: Nuclear Security: Nuclear Security Review 2025
Madam Chair:
We thank the Director General and the Secretariat for the preparation of document GOV/2025/6 of which we take note and accordingly issue the following considerations in our national capacity.
Cuba and Bolivia strengthen collaboration in nuclear medicine
Havana, February 17, 2025 - Cuba and Bolivia signed here Monday a collaboration agreement that will allow nuclear energy institutions of both countries to join knowledge and productive capacities to develop radiopharmaceuticals against cancer and other diseases.